Alexey Konov

Alexey Konov is a prominent figure in the venture capital and life sciences sectors, currently serving as the Founding Partner at RBV Capital, a role he held from 2012 until 2022. RBV Capital focuses on investments in the life sciences industry, leveraging Konov's extensive background in biotechnology and venture capital to support emerging companies in this field.

Professional Background

• Biovision Ventures: Currently, he is the Managing Partner at Biovision Ventures, a position he has held since November 2022. This venture capital firm is based in Luxembourg and specializes in life sciences investments.
• Board Roles: Konov has served as a Board Observer for PanDx Ltd since September 2021 and has held various board member positions, including roles at Bonti and RetroSense Therapeutics.
• Previous Experience: His prior experience includes positions such as Investment Director at Bioprocess Capital Partners and a Project Manager at Monsanto Company, where he worked on scientific outreach and technology transfer in Russia.

Education

Konov holds a Doctor of Philosophy (PhD) in Molecular Biology from the University Louis Pasteur, obtained between 1991 and 1994, and he graduated from Lomonosov Moscow State University in 1989.

Skills and Expertise

His expertise spans several areas including:

• Venture Capital
• Startups
• Private Equity
• Investments
• Biotechnology

Konov's career reflects a strong commitment to advancing the life sciences sector through strategic investments and governance roles, making him a key player in the industry.